WallStreetZenWallStreetZen

NASDAQ: VXRT
Vaxart Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for VXRT

Based on 1 analyst offering 12 month price targets for Vaxart Inc

Min Forecast
$2.00+354.55%
Avg Forecast
$2.00+354.55%
Max Forecast
$2.00+354.55%

Should I buy or sell VXRT stock?

Based on 1 analyst offering ratings for Vaxart Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their VXRT stock forecasts and price targets.

VXRT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-03-27

1 of 1

Forecast return on equity

Is VXRT forecast to generate an efficient return?

Company
-139.26%
Industry
142.9%
Market
80.27%
VXRT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is VXRT forecast to generate an efficient return on assets?

Company
-49.32%
Industry
35.65%
VXRT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

VXRT earnings per share forecast

What is VXRT's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.30
Avg 2 year Forecast
-$0.43
Avg 3 year Forecast
-$0.49

VXRT revenue forecast

What is VXRT's revenue in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
$13.4M-53.48%
Avg 2 year Forecast
$13.5M-53.14%
Avg 3 year Forecast
$15.8M-44.95%
VXRT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

VXRT revenue growth forecast

How is VXRT forecast to perform vs Biotechnology companies and vs the US market?

Company
-18.7%
Industry
64.17%
Market
10.07%
VXRT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
VXRT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

VXRT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
VXRT$0.44$2.00+354.55%Strong Buy
KYTX$2.31$16.00+592.64%Strong Buy
IFRX$1.70$9.33+449.00%Strong Buy
CSBR$7.15$12.00+67.83%Buy
ZNTL$1.42$6.04+325.35%Buy
View Top Biotech Stocks

Vaxart Stock Forecast FAQ

Is Vaxart Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: VXRT) stock is to Strong Buy VXRT stock.

Out of 1 analyst, 1 (100%) are recommending VXRT as a Strong Buy, 0 (0%) are recommending VXRT as a Buy, 0 (0%) are recommending VXRT as a Hold, 0 (0%) are recommending VXRT as a Sell, and 0 (0%) are recommending VXRT as a Strong Sell.

If you're new to stock investing, here's how to buy Vaxart stock.

What is VXRT's earnings growth forecast for 2025-2027?

(NASDAQ: VXRT) Vaxart's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12.96%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.59%.

Vaxart's earnings in 2025 is -$66,948,000.On average, 3 Wall Street analysts forecast VXRT's earnings for 2025 to be -$69,137,006, with the lowest VXRT earnings forecast at -$91,179,698, and the highest VXRT earnings forecast at -$54,707,819. On average, 2 Wall Street analysts forecast VXRT's earnings for 2026 to be -$96,878,429, with the lowest VXRT earnings forecast at -$113,974,623, and the highest VXRT earnings forecast at -$79,782,236.

In 2027, VXRT is forecast to generate -$110,555,384 in earnings, with the lowest earnings forecast at -$139,049,039 and the highest earnings forecast at -$82,061,728.

What is VXRT's revenue growth forecast for 2025-2027?

(NASDAQ: VXRT) Vaxart's forecast annual revenue growth rate of -18.7% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 64.17%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.07%.

Vaxart's revenue in 2025 is $28,700,000.On average, 2 Wall Street analysts forecast VXRT's revenue for 2025 to be $3,043,122,421, with the lowest VXRT revenue forecast at $2,325,082,299, and the highest VXRT revenue forecast at $3,761,162,543. On average, 2 Wall Street analysts forecast VXRT's revenue for 2026 to be $3,065,917,345, with the lowest VXRT revenue forecast at $1,755,209,187, and the highest VXRT revenue forecast at $4,376,625,504.

In 2027, VXRT is forecast to generate $3,601,598,071 in revenue, with the lowest revenue forecast at $1,071,361,452 and the highest revenue forecast at $6,131,834,691.

What is VXRT's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: VXRT) forecast ROA is -49.32%, which is lower than the forecast US Biotechnology industry average of 35.65%.

What is VXRT's Price Target?

According to 1 Wall Street analyst that have issued a 1 year VXRT price target, the average VXRT price target is $2.00, with the highest VXRT stock price forecast at $2.00 and the lowest VXRT stock price forecast at $2.00.

The Wall Street analyst predicted that Vaxart's share price could reach $2.00 by Mar 27, 2026. The average Vaxart stock price prediction forecasts a potential upside of 354.55% from the current VXRT share price of $0.44.

What is VXRT's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: VXRT) Vaxart's current Earnings Per Share (EPS) is -$0.33. On average, analysts forecast that VXRT's EPS will be -$0.30 for 2025, with the lowest EPS forecast at -$0.40, and the highest EPS forecast at -$0.24. On average, analysts forecast that VXRT's EPS will be -$0.43 for 2026, with the lowest EPS forecast at -$0.50, and the highest EPS forecast at -$0.35. In 2027, VXRT's EPS is forecast to hit -$0.49 (min: -$0.61, max: -$0.36).

What is VXRT's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: VXRT) forecast ROE is -139.26%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.